Extensive CD4 and CD8 T Cell cross-reactivity between alphaherpesviruses

Journal of Immunology

Volumn 196, Issue 5, 2016, Pages 2205-2218

  Jing, Lichen ^a   Laing, Kerry J ^a   Dong, Lichun ^a   Russell, Ronnie M ^a   Barlow, Russell S ^a   Haas, Juergen G ^b,c   Ramchandani, Meena S ^a   Johnston, Christine ^a   Buus, Soren ^d   Redwood, Alec J ^e   White, Katie D ^f   Mallal, Simon A ^e,f   Phillips, Elizabeth J ^e,f   Posavad, Christine M ^a,g   Wald, Anna ^a,g   Koelle, David M ^a,g,h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MURDOCH UNIVERSITY   (Australia)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g USA   (United States)

^h BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PEPTIDE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; VIRUS PROTEIN; CYTOKINE; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; VIRAL PROTEIN; VIRUS ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; EMBRYO; GENE SEQUENCE; HERPES SIMPLEX VIRUS; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMORY CELL; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN FIBROBLAST; TCRB GENE; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION; VIRUS IMMUNITY; ALPHAHERPESVIRINAE; ANTIGEN PRESENTATION; GENETICS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ALPHAHERPESVIRINAE; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

EID: 84962031561     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502366     Document Type: Article

References (82)

1. Baxter, R., T. N. Tran, P. Ray, E. Lewis, B. Fireman, S. Black, H. R. Shinefield, P. M. Coplan, and P. Saddier. 2014. Impact of vaccination on the epidemiology of varicella: 1995-2009. Pediatrics 134: 24-30.
2. Leung, J., R. Harpaz, N. A. Molinari, A. Jumaan, and F. Zhou. 2011. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin. Infect. Dis. 52: 332-340.
3. Nysse, L. J., N. A. Pinsky, J. P. Bratberg, A. Y. Babar-Weber, T. T. Samuel, E. H. Krych, A. W. Ziegler, M. A. Jimale, R. A. Vierkant, R. M. Jacobson, and G. A. Poland. 2007. Seroprevalence of antibody to varicella among Somali refugees. Mayo Clin. Proc. 82: 175-180.
4. Thomas, F., E. Elguero, J. Brodeur, J. Le Goff, and D. Missé. 2011. Herpes simplex virus type 2 and cancer: a medical geography approach. Infect. Genet. Evol. 11: 1239-1242.
5. Bradley, H., L. E. Markowitz, T. Gibson, and G. M. McQuillan. 2014. Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999-2010. J. Infect. Dis. 209: 325-333.
6. Bernstein, D. I., A. R. Bellamy, E. W. Hook, III, M. J. Levin, A. Wald, M. G. Ewell, P. A. Wolff, C. D. Deal, T. C. Heineman, G. Dubin, and R. B. Belshe. 2013. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin. Infect. Dis. 56: 344-351.
7. Hope-Simpson, R. E. 1965. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc. R. Soc. Med. 58: 9-20.
8. Ogunjimi, B., L. Willem, P. Beutels, and N. Hens. 2015. Integrating betweenhost transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. eLife 4: 4.
9. Hales, C. M., R. Harpaz, M. R. Joesoef, and S. R. Bialek. 2013. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann. Intern. Med. 159: 739-745.
10. Cohen, J. I. 2010. The varicella-zoster virus genome. In Current Topics in Immunology and Microbiology: Varicella-zoster Virus. A. Abendroth, A. M. Arvin, and J. F. Moffat, eds. Springer, Berlin, p. 1-14.
11. Ross, C. A., J. H. Subak Sharpe, and P. Ferry. 1965. Antigenic relationship of varicella-zoster and herpes simplex. Lancet 2: 708-711.
12. Kapsenberg, J. G. 1964. Possible Antigenic Relationship between Varicella Zoster Virus and Herpes Simplex Virus. Arch. Gesamte Virusforsch. 15: 67-73.
13. Schmidt, N. J., E. H. Lennette, and R. L. Magoffin. 1969. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complementfixation, neutralization and fluorescent antibody tests. J. Gen. Virol. 4: 321-328.
14. Posavad, C. M., A. Wald, N. Hosken, M. L. Huang, D. M. Koelle, R. L. Ashley, and L. Corey. 2003. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity? J. Immunol. 170: 4380-4388.
15. Posavad, C. M., M. Remington, D. E. Mueller, L. Zhao, A. S. Magaret, A. Wald, and L. Corey. 2010. Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons. J. Immunol. 184: 3250-3259.
16. Laing, K. J., R. M. Russell, L. Dong, D. S. Schmid, M. Stern, A. Magaret, J. G. Haas, C. Johnston, A. Wald, and D. M. Koelle. 2015. Zoster vaccination increases the breadth of CD4+ T cells responsive to varicella zoster virus. J. Infect. Dis. 212: 1022-1031.
17. Crosslin, D. R., D. S. Carrell, A. Burt, D. S. Kim, J. G. Underwood, D. S. Hanna, B. A. Comstock, E. Baldwin, M. de Andrade, I. J. Kullo, et al. 2015. Genetic variation in the HLA region is associated with susceptibility to herpes zoster. Genes Immun. 16: 1-7.
18. Weinberg, A., and M. J. Levin. 2010. VZV T cell-mediated immunity. In Varicella-zoster Virus. A. Abendroth, A. M. Arvin, and J. F. Moffat, eds. Springer, Berlin, p. 341-357.
19. Gilbert, P. B., E. E. Gabriel, X. Miao, X. Li, S. C. Su, J. Parrino, and I. S. Chan. 2014. Fold rise in antibody titers by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve. J. Infect. Dis. 210: 1573-1581.
20. Chiu, C., M. McCausland, J. Sidney, F. M. Duh, N. Rouphael, A. Mehta, M. Mulligan, M. Carrington, A. Wieland, N. L. Sullivan, et al. 2014. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog. 10: e1004008.
21. Oxman, M. N., M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, et al; Shingles Prevention Study Group. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352: 2271-2284.
22. Schmader, K. E., M. J. Levin, J. W. Gnann, Jr., S. A. McNeil, T. Vesikari, R. F. Betts, S. Keay, J. E. Stek, N. D. Bundick, S. C. Su, et al. 2012. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin. Infect. Dis. 54: 922-928.
23. Lal, H., A. L. Cunningham, O. Godeaux, R. Chlibek, J. Diez-Domingo, S.-J.Hwang, M. J. Levin, J. E.McElhaney, A. Poder, J. Puig-Barberà, et al; ZOE- 50 Study Group. 2015. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372: 2087-2096.
24. Johnston, C., J. Zhu, L. Jing, K. J. Laing, C. M. McClurkan, A. Klock, K. Diem, L. Jin, J. Stanaway, E. Tronstein, et al. 2014. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection. J. Virol. 88: 4921-4931.
25. Jing, L., J. Haas, T. M. Chong, J. J. Bruckner, G. C. Dann, L. Dong, J. O. Marshak, C. L. McClurkan, T. N. Yamamoto, S. M. Bailer, et al. 2012. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J. Clin. Invest. 122: 654-673.
26. van Velzen, M., L. Jing, A. D. Osterhaus, A. Sette, D. M. Koelle, and G. M. Verjans. 2013. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog. 9: e1003547.
27. Jing, L., J. T. Schiffer, T. M. Chong, J. J. Bruckner, D. H. Davies, P. L. Felgner, J. Haas, A. Wald, G. M. Verjans, and D. M. Koelle. 2013. CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence. J. Virol. 87: 2617-2627.
28. Pavlos, R., S. Mallal, D. Ostrov, Y. Pompeu, and E. Phillips. 2014. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J. Allergy Clin. Immunol. Pract. 2: 21-33.
29. Strachan, E., C. Hunt, N. Afari, G. Duncan, C. Noonan, E. Schur, N. Watson, J. Goldberg, and D. Buchwald. 2013. University of Washington Twin Registry: poised for the next generation of twin research. Twin Res. Hum. Genet. 16: 455-462.
30. Ramchandani, M. S., R. M. Russell, L. Jing, A. Magaret, S. Selke, M. L. Huang, E. Strachan, A. Wald, and D. M. Koelle. 2014. Host and pathogen genetics modulate HSV-1 severity. Infectious Diseases Society of America, Philadelphia, PA (abstract 1154).
31. Koelle, D. M., M. A. Tigges, R. L. Burke, F. W. Symington, S. R. Riddell, H. Abbo, and L. Corey. 1993. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J. Clin. Invest. 91: 961-968.
32. Koelle, D. M., L. Corey, R. L. Burke, R. J. Eisenberg, G. H. Cohen, R. Pichyangkura, and S. J. Triezenberg. 1994. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68: 2803-2810.
33. Laing, K. J., A. S. Magaret, D. E. Mueller, L. Zhao, C. Johnston, S. C. De Rosa, D. M. Koelle, A. Wald, and L. Corey. 2010. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes. J. Clin. Immunol. 30: 703-722.
34. Linnemann, C., B. Heemskerk, P. Kvistborg, R. J. Kluin, D. A. Bolotin, X. Chen, K. Bresser, M. Nieuwland, R. Schotte, S. Michels, et al. 2013. High-throughput identification of antigen-specific TCRs by TCR gene capture. Nat. Med. 19: 1534-1541.
35. Koelle, D. M., H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166: 4049-4058.
36. Varadarajan, N., B. Julg, Y. J. Yamanaka, H. Chen, A. O. Ogunniyi, E. McAndrew, L. C. Porter, A. Piechocka-Trocha, B. J. Hill, D. C. Douek, et al. 2011. A high-throughput single-cell analysis of human CD8+ T cell functions reveals discordance for cytokine secretion and cytolysis. J. Clin. Invest. 121: 4322-4331.
37. Zhou, Q., I. C. Schneider, I. Edes, A. Honegger, P. Bach, K. Schönfeld, A. Schambach, W. S. Wels, S. Kneissl, W. Uckert, and C. J. Buchholz. 2012. T-cell receptor gene transfer exclusively to human CD8(+) cells enhances tumor cell killing. Blood 120: 4334-4342.
38. Koelle, D. M. 2003. Expression cloning for the discovery of viral antigens and epitopes recognized by T cells. Methods 29: 213-226.
39. Hanley, P. J., J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, et al. 2015. CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo. Sci. Transl. Med. 7: 285ra63.
40. Moss, N. J., A. Magaret, K. J. Laing, A. Shaulov Kask, M. Wang, K. E. Mark, J. T. Schiffer, A. Wald, and D. M. Koelle. 2012. Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes. J. Virol. 86: 9952-9963.
41. Stanke, J., C. Hoffmann, U. Erben, H. von Keyserling, S. Stevanovic, G. Cichon, A. Schneider, and A. M. Kaufmann. 2010. A flow cytometry-based assay to assess minute frequencies of CD8+ T cells by their cytolytic function. J. Immunol. Methods 360: 56-65.
42. Chung, N., X. D. Zhang, A. Kreamer, L. Locco, P. F. Kuan, S. Bartz, P. S. Linsley, M. Ferrer, and B. Strulovici. 2008. Median absolute deviation to improve hit selection for genome-scale RNAi screens. J. Biomol. Screen. 13: 149-158.
43. Malo, N., J. A. Hanley, S. Cerquozzi, J. Pelletier, and R. Nadon. 2006. Statistical practice in high-throughput screening data analysis. Nat. Biotechnol. 24: 167-175.
44. Wuest, T., B. A. Austin, S. Uematsu, M. Thapa, S. Akira, and D. J. Carr. 2006. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 179: 46-52.
45. Stewart, J. J., C. Y. Lee, S. Ibrahim, P. Watts, M. Shlomchik, M. Weigert, and S. Litwin. 1997. A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol. Immunol. 34: 1067-1082.
46. Peters, G. A., S. D. Tyler, J. E. Carpenter, W. Jackson, Y. Mori, A. M. Arvin, and C. Grose. 2012. The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation. J. Virol. 86: 10695-10703.
47. Belshe, R. B., P. A. Leone, D. I. Bernstein, A. Wald, M. J. Levin, J. T. Stapleton, I. Gorfinkel, R. L. Morrow, M. G. Ewell, A. Stokes-Riner, et al; Herpevac Trial for Women. 2012. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med. 366: 34-43.
48. Ouwendijk, W. J., A. Geluk, S. L. Smits, S. Getu, A. D. Osterhaus, and G. M. Verjans. 2014. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells. J. Immunol. 192: 3730-3739.
49. Malavige, G. N., L. Jones, A. P. Black, and G. S. Ogg. 2007. Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection. J. Infect. Dis. 195: 660-664.
50. Tronstein, E., C. Johnston, M. L. Huang, S. Selke, A. Magaret, T. Warren, L. Corey, and A. Wald. 2011. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305: 1441-1449.
51. Tigges, M. A., D. Koelle, K. Hartog, R. E. Sekulovich, L. Corey, and R. L. Burke. 1992. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66: 1622-1634.
52. Cohen, J. I. 1998. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J. Infect. Dis. 177: 1390-1393.
53. van Velzen, M., L. Jing, A. D. M. E. Osterhaus, D. M. Koelle, and G. M. G. M. Verjans. 2012. HSV-1-specific T-cells in latently infected human trigeminal ganglia recognized a restricted set of viral proteins. In 37th International Herpesvirus Workshop, August 2, 2012. Calgary, Alberta, Canada, abstract 5.05.
54. Kim, Y., A. Sette, and B. Peters. 2011. Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource. J. Immunol. Methods 374: 62-69.
55. Vita, R., L. Zarebski, J. A. Greenbaum, H. Emami, I. Hoof, N. Salimi, R. Damle, A. Sette, and B. Peters. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38: D854-D862.
56. Dong, L., P. Li, T. Oenema, C. L. McClurkan, and D. M. Koelle. 2010. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J. Immunol. 184: 3063-3071.
57. Yasukawa, M., and J. M. Zarling. 1984. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. J. Immunol. 133: 2736-2742.
58. Pellett, P. E., and B. Roizman. 2013. Herpesviridae. In Fields Virology, 6th Ed. D. M. Knipe, P. M. Howley, J. I. Cohen, D. E. Griffin, R. A. Lamb, M. A. Martin, V. R. Racaniello, and B. Roizman, eds. Lippincott Williams and Wilkins, Philadelphia, p. 1802-1822.
59. Chakradhar, S. 2015. Updated, augmented vaccines compete with original antigenic sin. Nat. Med. 21: 540-541.
60. Koelle, D. M., H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166: 4049-4058.
61. Dervillez, X., H. Qureshi, A. A. Chentoufi, A. A. Khan, E. Kritzer, D. C. Yu, O. R. Diaz, C. Gottimukkala, M. Kalantari, M. C. Villacres, et al. 2013. Asymptomatic HLA-A∗02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes. J. Immunol. 191: 5124-5138.
62. Srivastava, R., A. A. Khan, D. Spencer, H. Vahed, P. P. Lopes, N. T. Thai, C. Wang, T. T. Pham, J. Huang, V. M. Scarfone, et al. 2015. HLA-A02:01- restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLAA∗ 02:01 transgenic mice against ocular herpes. J. Immunol. 194: 2232-2248.
63. Schub, D., E. Janssen, S. Leyking, U. Sester, G. Assmann, P. Hennes, S. Smola, T. Vogt, T. Rohrer, M. Sester, and T. Schmidt. 2015. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. J. Infect. Dis. 211: 600-612.
64. Weinberg, A., J. H. Zhang, M. N. Oxman, G. R. Johnson, A. R. Hayward, M. J. Caulfield, M. R. Irwin, J. Clair, J. G. Smith, H. Stanley, et al; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators. 2009. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J. Infect. Dis. 200: 1068-1077.
65. Zerboni, L., B. Berarducci, J. Rajamani, C. D. Jones, J. L. Zehnder, and A. Arvin. 2011. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis. J. Virol. 85: 98-111.
66. Fowler, W. J., M. Garcia-Valcarcel, M. S. Hill-Perkins, G. Murphy, D. R. Harper, D. J. Jeffries, N. R. Burns, S. E. Adams, A. J. Kingsman, and G. T. Layton. 1995. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. Virology 214: 531-540.
67. Bergen, R. E., M. Sharp, A. Sanchez, A. K. Judd, and A. M. Arvin. 1991. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral Immunol. 4: 151-166.
68. Long, D., M. Skoberne, T. M. Gierahn, S. Larson, J. A. Price, V. Clemens, A. E. Baccari, K. P. Cohane, D. Garvie, G. R. Siber, and J. B. Flechtner. 2014. Identification of novel virus-specific antigens by CD4+ and CD8+ T cells from asymptomatic HSV-2 seropositive and seronegative donors. Virology 464-465: 296-311.
69. Wald, A., L. Fife, S. Tyring, P. Lee, N. Van Wagoner, D. Bernstein, J. B. Flechtner, A. Magaret, A. Morris, and S. Hetherington. 2014. Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year. In IDweek 2014, October 8, 2014. Philadelphia, PA. Abstract 1333. Infectious Diseases Society of America, Arlington, VA.
70. Kwok, W. W., A. W. Liu, E. J. Novak, J. A. Gebe, R. A. Ettinger, G. T. Nepom, S. N. Reymond, and D. M. Koelle. 2000. HLA-DQ tetramers identify epitopespecific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J. Immunol. 164: 4244-4249.
71. Novak, E. J., A. W. Liu, J. A. Gebe, B. A. Falk, G. T. Nepom, D. M. Koelle, and W. W. Kwok. 2001. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J. Immunol. 166: 6665-6670.
72. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183: 1253-1258.
73. Blyth, E., S. S. Gaundar, L. Clancy, R. M. Simms, I. Bilmon, K. P. Micklethwaite, and D. J. Gottlieb. 2012. Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients. Cytotherapy 14: 724-732.
74. Chapuis, A. G., O. K. Afanasiev, J. G. Iyer, K. G. Paulson, U. Parvathaneni, J. H. Hwang, I. Lai, I. M. Roberts, H. L. Sloan, S. Bhatia, et al. 2014. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I. Cancer Immunol. Res. 2: 27-36.
75. Nivarthi, U. K., S. Gras, L. Kjer-Nielsen, R. Berry, I. S. Lucet, J. J. Miles, S. L. Tracy, A. W. Purcell, D. S. Bowden, M. Hellard, et al. 2014. An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant. J. Immunol. 193: 5402-5413.
76. Motozono, C., N. Kuse, X. Sun, P. J. Rizkallah, A. Fuller, S. Oka, D. K. Cole, A. K. Sewell, and M. Takiguchi. 2014. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B∗51:01. J. Immunol. 192: 3428-3434.
77. Mallal, S., D. Nolan, C. Witt, G. Masel, A. M. Martin, C. Moore, D. Sayer, A. Castley, C. Mamotte, D. Maxwell, et al. 2002. Association between presence of HLA-B∗5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359: 727-732.
78. Illing, P. T., J. P. Vivian, N. L. Dudek, L. Kostenko, Z. Chen, M. Bharadwaj, J. J. Miles, L. Kjer-Nielsen, S. Gras, N. A. Williamson, et al. 2012. Immune selfreactivity triggered by drug-modified HLA-peptide repertoire. Nature 486: 554-558.
79. Ostrov, D. A., B. J. Grant, Y. A. Pompeu, J. Sidney, M. Harndahl, S. Southwood, C. Oseroff, S. Lu, J. Jakoncic, C. A. de Oliveira, et al. 2012. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc. Natl. Acad. Sci. USA 109: 9959-9964.
80. Sewell, A. K. 2012. Why must T cells be cross-reactive? Nat. Rev. Immunol. 12: 669-677.
81. Su, L. F., B. A. Kidd, A. Han, J. J. Kotzin, and M. M. Davis. 2013. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 38: 373-383.
82. Haluszczak, C., A. D. Akue, S. E. Hamilton, L. D. Johnson, L. Pujanauski, L. Teodorovic, S. C. Jameson, and R. M. Kedl. 2009. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 206: 435-448.